Back to Search

JAMES RUETHER, MD

MD

Internal Medicine Physician

NPI: 1154391928IndividualAccepts Medicare

Specialties, Licenses & Credentials

Internal Medicine PhysicianPrimary

Internal Medicine

Code: 207R00000X

C10004869(DE)

CMS Specialties

PrimaryINTERNAL MEDICINE

Additional

GERIATRIC MEDICINEHOSPITALIST

Education

OTHER

Class of 1993

Research & Publications (15)

Predictors of distress and quality of life in patients undergoing cancer therapy: impact of treatment type and decisional role.
PMID 19557823·Psychooncology·2010
8-other
Behind closed doors: systematic analysis of breast cancer consultation communication and predictors of satisfaction with communication.
PMID 19514095·Psychooncology·2010
8-other
Intermittent chemotherapy in patients with metastatic androgen-independent prostate cancer: results from ASCENT, a double-blinded, randomized comparison of high-dose calcitriol plus docetaxel with placebo plus docetaxel.
PMID 17960793·Cancer·2008
4-observational
C-reactive protein as a prognostic marker for men with androgen-independent prostate cancer: results from the ASCENT trial.
PMID 18428198·Cancer·2008
4-observational
A phase II study of sorafenib in patients with chemo-naive castration-resistant prostate cancer.
PMID 18056648·Ann Oncol·2008
3-trial
Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT Investigators.
PMID 17308271·J Clin Oncol·2007
4-observational
Clinical experience of the multimodality management of anaplastic thyroid cancer and literature review.
PMID 18177257·Thyroid·2007
6-review
Psychosocial barriers to active surveillance for the management of early prostate cancer and a strategy for increased acceptance.
PMID 17532857·BJU Int·2007
6-review
Impact of providing audiotapes of primary treatment consultations to men with prostate cancer: a multi-site, randomized, controlled trial.
PMID 16991107·Psychooncology·2007
4-observational
High-dose mitoxantrone-vinblastine-cyclophosphamide and autologous stem cell transplantation for stage III breast cancer: final results of a prospective multicentre study.
PMID 15946980·Ann Oncol·2005
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Request Appointment

Contact & Hours

Address
200 HYGEIA DRIVE, SUITE 2100
NEWARK, DE 19713

Quick Facts

NPI
1154391928
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
1
Locations
1
Years in Practice
33
Publications
15

Are you this provider?

Claim Your Profile